The aim of this study was to radiolabel Bevacizumab with ( 99m ) Tc and to evaluate in vivo its imaging properties in an adenocarcinoma animal model .
The aim of this study was to radiolabel sorafenib ( 1 ) with carbon - 11 and to evaluate its potential as TKI - PET tracer in vivo .
Our goal was to radiolabel an antibody at several iodine : antibody molar ratios under conditions protecting its combining site and to compare its immunoreactive fraction ( IRF ) and electrophoretic mobility with those of the same antibody radiolabeled without protection .
